Self care: Tips on Managing Fatigue

Image result for Self care: Managing fatigue youtube nhs

 

Dr Andrew Field, GP and partner at York Medical Group, offers practical advice about how to manage fatigue using self-help advice and over-the-counter remedies.

What Does MS Fatigue REALLY Feel LIke?

Image result for What Does MS Fatigue REALLY Feel LIke?

Bringing to light exactly what Ms fatigue is and what it feels like. How it is not anywhere close to regular fatigue and also discussing the relationship and the struggle between Ms fatigue and physical exercise. Below is my blog about what living with MS is like for me!

Primer on Managing FATIGUE in Multiple Sclerosis

Image result for Primer on Managing FATIGUE in Multiple Sclerosis

Dr. B discusses MS fatigue. Topics include: causes of fatigue, functional neurological reserve, spoon theory, different types of MS fatigue, contributing factors worsening fatigue. Dr.B finishes by providing 10 TIPS to help YOU combat MS fatigue!

Online Fatigue Management Feasible, Effective for Multiple Sclerosis

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome

Self-guided, online, therapy-based interventions may be effective in improving symptoms of fatigue in patients with multiple sclerosis (MS), according to the results of a study reported in the Journal of Neurology, Neurosurgery, and Psychiatry.

Fatigue is significantly disabling in patients with MS. Therapy may be used in management; however, patients are often limited from participation in one-on-one, office-based appointments due to their symptoms, costs, and the availability of qualified professionals.

Investigators designed a parallel-group, 2-arm, randomized controlled trial to evaluate ELEVIDA, an online fatigue management program based on cognitive behavioral therapy and other therapy-based strategies.

Patients were recruited online through the German MS society website and randomly assigned (1:1) to one of two groups: ELEVIDA (n=139, 82% female, median patient determined disease steps (PDDS) 3.0) or waitlist control group (n=136, 79% female, median PDDS 3.0). Outcomes were measured at baseline, post-intervention (week 12), and follow-up (week 24).

Read more here.